ACRV → $7.00 by Dec 23, 2026.

I’ve been digging pretty heavily into $ACRV for the past 6 months and it’s finally reaching its most critical point. In the next 3 months, before the end of 2026, we will see its phase2b result. That upcoming readout is undoubtedly the biggest and most important in the companies history. If the response rate for its drug (ACR-368) holds close to what they’ve already shown, I think the market will seriously reevaluate what the company is worth. One thing getting …